MedTrace Logo

Traditional Versus Progressive Robot-assisted Gait Training in People With Multiple Sclerosis and Severe Gait Disability

NCT06381440 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-04-24

No results posted yet for this study

Summary

Multiple sclerosis (MS) is a demyelinating neurodegenerative disease. Qualitative alterations in walking function in MS people involve 75% of subjects with MS and are determined by reduced coordination, mobility, balance, and increased risk of falling. Robot assisted gait training (RAGT) devices seem effective in MS patients with severe motor disabilities, failing to show significant superiority when compared to intensive overground gait rehabilitation (OGT). This study aims to evaluate the effects of a low-intensity RAGT at progressively increasing intensity compared to conventional RAGT and OGT.

Conditions

Interventions

DEVICE

Lokomat device (Hocoma AG, Volketswil, Switzerland).

Robot Assisted Gait Training device

OTHER

Conventional walking training

Self-paced supervised walking training

Sponsors & Collaborators

  • Universita di Verona

    collaborator OTHER

  • Università degli Studi di Ferrara

    collaborator OTHER

  • University Hospital of Ferrara

    lead OTHER

Principal Investigators

  • Fabio Manfredini, PhD · Ferrara University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-15
Primary Completion
2024-11-30
Completion
2024-11-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06381440 on ClinicalTrials.gov